David J Salant

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Boston Medical Center Corporation, Pfizer Corporation, Centre National De La Recherche Scientifique. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Salant. Retrieved from https://idiyas.com/inventor/david-j-salant-8ap2h49k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Newton, MA (US) (2013 - 2019)
Boston, MA (US) (2021 - 2024)

Company Filing History:

6 out of 62

Boston Medical Center Corporation

Centre National De La Recherche Scientifique

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11970524 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2024-04-30),

2. 11365253 - Anti-ROBO2 antibodies, compositions, methods and uses thereof (2022-06-21),

3. 10906955 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2021-02-02),

4. 10358677 - Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2 (2019-07-23),

5. 9572879 - ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2 (2017-02-21),

6. 8507215 - Diagnostics for membranous nephropathy (2013-08-13),

Title: David J Salant: Innovator in Recombinant Proteins

Introduction

David J Salant is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of 6 patents to his name, Salant's work has advanced our understanding of protein interactions and their applications in medicine.

Latest Patents

Salant's latest patents include innovative inventions such as recombinant ROBO2 proteins, compositions, methods, and uses thereof. This invention provides recombinant Roundabout Receptor 2 (ROBO2) proteins designed to bind SLIT ligands, effectively preventing their binding to ROBO2 cell surface receptors. Additionally, he has developed anti-ROBO2 antibodies, compositions, methods, and uses thereof. This invention offers antibodies and antigen-binding fragments that specifically bind to ROBO2, along with various applications and methods for their use.

Career Highlights

Throughout his career, David J Salant has worked with prominent organizations, including Boston Medical Center Corporation and Pfizer Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Salant has collaborated with notable colleagues such as Weining Lu and Xueping Fan. These partnerships have further enriched his research and innovation efforts.

Conclusion

David J Salant's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant innovator. His work continues to impact the development of therapeutic solutions in medicine.

Profile summary based on public USPTO records.